Cargando…
Immune Intervention in Sepsis
Sepsis is a host immune disorder induced by infection. It can lead to multiple organ dysfunction syndrome (MODS), which has high morbidity and mortality. There has been great progress in the clinical diagnosis and treatment of sepsis, such as improvements in pathogen detection technology, innovation...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317843/ https://www.ncbi.nlm.nih.gov/pubmed/34335278 http://dx.doi.org/10.3389/fphar.2021.718089 |
_version_ | 1783730131347439616 |
---|---|
author | Chen, Jian Wei, Haiming |
author_facet | Chen, Jian Wei, Haiming |
author_sort | Chen, Jian |
collection | PubMed |
description | Sepsis is a host immune disorder induced by infection. It can lead to multiple organ dysfunction syndrome (MODS), which has high morbidity and mortality. There has been great progress in the clinical diagnosis and treatment of sepsis, such as improvements in pathogen detection technology, innovations regarding anti-infection drugs, and the development of organ function support. Abnormal immune responses triggered by pathogens, ranging from excessive inflammation to immunosuppression, are recognized to be an important cause of the high mortality rate. However, no drugs have been approved specifically for treating sepsis. Here, we review the recent research progress on immune responses in sepsis to provide a theoretical basis for the treatment of sepsis. Constructing and optimizing a dynamic immune system treatment regimen based on anti-infection treatment, fluid replacement, organ function support, and timely use of immunomodulatory interventions may improve the prognosis of sepsis patients. |
format | Online Article Text |
id | pubmed-8317843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83178432021-07-29 Immune Intervention in Sepsis Chen, Jian Wei, Haiming Front Pharmacol Pharmacology Sepsis is a host immune disorder induced by infection. It can lead to multiple organ dysfunction syndrome (MODS), which has high morbidity and mortality. There has been great progress in the clinical diagnosis and treatment of sepsis, such as improvements in pathogen detection technology, innovations regarding anti-infection drugs, and the development of organ function support. Abnormal immune responses triggered by pathogens, ranging from excessive inflammation to immunosuppression, are recognized to be an important cause of the high mortality rate. However, no drugs have been approved specifically for treating sepsis. Here, we review the recent research progress on immune responses in sepsis to provide a theoretical basis for the treatment of sepsis. Constructing and optimizing a dynamic immune system treatment regimen based on anti-infection treatment, fluid replacement, organ function support, and timely use of immunomodulatory interventions may improve the prognosis of sepsis patients. Frontiers Media S.A. 2021-07-14 /pmc/articles/PMC8317843/ /pubmed/34335278 http://dx.doi.org/10.3389/fphar.2021.718089 Text en Copyright © 2021 Chen and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Chen, Jian Wei, Haiming Immune Intervention in Sepsis |
title | Immune Intervention in Sepsis |
title_full | Immune Intervention in Sepsis |
title_fullStr | Immune Intervention in Sepsis |
title_full_unstemmed | Immune Intervention in Sepsis |
title_short | Immune Intervention in Sepsis |
title_sort | immune intervention in sepsis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317843/ https://www.ncbi.nlm.nih.gov/pubmed/34335278 http://dx.doi.org/10.3389/fphar.2021.718089 |
work_keys_str_mv | AT chenjian immuneinterventioninsepsis AT weihaiming immuneinterventioninsepsis |